Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated platform for health plan administration and value-based business infrastructure. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management; and Machinify Auth, a software platform that leverages advances in artificial intelligence. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
Market Adaptation | Delve into Evolent's efforts to navigate industry changes, including Medicare Advantage shifts and the potential for strategic acquisitions |
Financial Resilience | Despite challenges, Evolent projects 2025 revenue between $2.06-2.11 billion, with analysts setting price targets ranging from $12 to $39 |
AI-Driven Future | Explore Evolent's strategic investments in artificial intelligence, poised to create cost efficiencies and enhance competitiveness by 2025 |
Oncology Cost Crisis | Evolent Health grapples with rising cancer care expenses, impacting its Performance Suite business and necessitating strategic contract renegotiations |
Metrics to compare | EVH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEVHPeersSector | |
---|---|---|---|---|
P/E Ratio | −12.1x | −0.7x | −0.5x | |
PEG Ratio | −0.32 | −0.02 | 0.00 | |
Price / Book | 1.1x | 1.7x | 2.6x | |
Price / LTM Sales | 0.4x | 0.7x | 2.9x | |
Upside (Analyst Target) | 49.9% | 23.9% | 56.4% | |
Fair Value Upside | Unlock | 35.5% | 9.3% | Unlock |